Number of Participants Reporting Serious Adverse Experiences (SAE) in the Vaccination and Follow-up Phases Day 1 through Month 18 [clinicaltrials_resource:33452beb716dca7222233808a7910e77]
Tolerability as assessed by the number of participants with clinical adverse experiences in the Vaccination and Follow-up Phases. A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an "other important medical event" based on medical judgment.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of Participants Reporting Serious Adverse Experiences (SAE) in the Vaccination and Follow-up Phases Day 1 through Month 18 [clinicaltrials_resource:33452beb716dca7222233808a7910e77]
Tolerability as assessed by the number of participants with clinical adverse experiences in the Vaccination and Follow-up Phases. A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an "other important medical event" based on medical judgment.
Bio2RDF identifier
33452beb716dca7222233808a7910e77
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:33452beb716dca7222233808a7910e77
measure [clinicaltrials_vocabulary:measure]
Number of Participants Reporti ...... ccination and Follow-up Phases
time frame [clinicaltrials_vocabulary:time-frame]
Day 1 through Month 18
description
Tolerability as assessed by th ...... nt" based on medical judgment.
identifier
clinicaltrials_resource:33452beb716dca7222233808a7910e77
title
Number of Participants Reporti ...... Phases Day 1 through Month 18
@en
type
label
Number of Participants Reporti ...... 52beb716dca7222233808a7910e77]
@en